Pulmonary embolism (PE) is a serious medical condition that can lead to a range of symptoms and complications. One of the most common signs of PE is an elevated heart rate, which can be caused by the increased demand on the right ventricle of the heart. This can lead to a range of other symptoms, including shortness of breath, chest pain, and coughing.

Another common sign of PE is the presence of S1Q3T3 on an electrocardiogram (ECG). This is characterized by a deep S-wave in lead I, a Q-wave in lead III, and an inverted T-wave in lead III. While this finding is associated with PE, it is not specific to the condition and may not be present in all cases.

T-wave inversions in leads V1-V4 can also be a sign of right ventricular strain, which can occur as a result of the increased demand on the heart caused by PE. However, this is not the most common finding in cases of PE.

Pulmonary embolism can be difficult to diagnose as it can present with a variety of cardiorespiratory symptoms and signs depending on its location and size. The PIOPED study in 2007 found that tachypnea, crackles, tachycardia, and fever were common clinical signs in patients diagnosed with pulmonary embolism. The Well’s criteria for diagnosing a PE use tachycardia rather than tachypnea. All patients with symptoms or signs suggestive of a PE should have a history taken, examination performed, and a chest x-ray to exclude other pathology.

To rule out a PE, the pulmonary embolism rule-out criteria (PERC) can be used. All criteria must be absent to have a negative PERC result, which reduces the probability of PE to less than 2%. If the suspicion of PE is greater than this, a 2-level PE Wells score should be performed. A score of more than 4 points indicates a likely PE, and an immediate computed tomography pulmonary angiogram (CTPA) should be arranged. If the CTPA is negative, patients do not need further investigations or treatment for PE.

CTPA is now the recommended initial lung-imaging modality for non-massive PE. V/Q scanning may be used initially if appropriate facilities exist, the chest x-ray is normal, and there is no significant symptomatic concurrent cardiopulmonary disease. D-dimer levels should be considered for patients over 50 years old. A chest x-ray is recommended for all patients to exclude other pathology, but it is typically normal in PE. The sensitivity of V/Q scanning is around 75%, while the specificity is 97%. Peripheral emboli affecting subsegmental arteries may be missed on CTPA.

Medication Options for Angina and Hypertension

The National Institute for Health and Care Excellence (NICE) recommends considering treatment with an angiotensin-converting enzyme (ACE) inhibitor for secondary prevention in patients with stable angina and diabetes mellitus, as long as there are no contraindications. This should also be prescribed where there is co-existing hypertension, left ventricular dysfunction, chronic kidney disease, or previous myocardial infarction (MI).

Amlodipine is a calcium-channel blocker which could be added to control hypertension; however, this patient’s blood pressure is normal on current therapy.

Diltiazem is a non-dihydropyridine calcium-channel blocker which can be used as an alternative first-line treatment in angina. This patient is already on atenolol and is well controlled.

Doxazosin is an alpha-blocker used in the management of hypertension. This patient’s blood pressure is within normal limits, so it is not currently indicated.

Nicorandil is an anti-anginal medication due to its vasodilatory properties which can be added or used as a monotherapy when symptoms of angina are not controlled with a beta-blocker or calcium-channel blocker or these are not tolerated. This patient’s symptoms are controlled on atenolol, so nicorandil is not indicated.

The sudden appearance of linear, well-defined skin lesions with a lack of concern or emotional response, known as ‘la belle indifference’, strongly suggests dermatitis artefacta or factitious dermatitis. This rare condition involves self-inflicted skin damage, and patients often deny their involvement. Treatment requires a collaborative approach between dermatologists and psychiatrists, with a focus on building a positive relationship with the patient. Other conditions such as dermatitis herpetiformis, lichen planus, and neurotic excoriations have different clinical presentations and are not consistent with the scenario described.

Understanding Dermatitis Artefacta

Dermatitis artefacta is a rare condition that affects individuals of any age, but is more common in females. It is characterised by self-inflicted skin lesions that patients typically deny are self-induced. The condition is strongly associated with personality disorder, dissociative disorders, and eating disorders, with a prevalence of up to 33% in patients with bulimia or anorexia.

Patients with dermatitis artefacta present with well-demarcated linear or geometric lesions that appear suddenly and do not evolve over time. The lesions may be caused by scratching with fingernails or other objects, burning skin with cigarettes, or chemical exposure. Commonly affected areas include the face and dorsum of the hands. Despite the severity of the skin lesions, patients may display a nonchalant attitude, known as la belle indifference.

Diagnosis of dermatitis artefacta is based on clinical history and exclusion of other dermatological conditions. Biopsy of skin lesions is not routine but may be helpful to exclude other conditions. Psychiatric assessment may be necessary. Differential diagnosis includes other dermatological conditions and factitious disorders such as Munchausen syndrome and malingering.

Management of dermatitis artefacta involves a multidisciplinary approach with dermatologists, psychologists, and psychiatrists. Direct confrontation is unhelpful and may discourage patients from seeking medical help. Treatment includes providing occlusive dressing, topical antibiotics, and bland emollients. Selective serotonin reuptake inhibitors and cognitive behavioural therapy may be helpful, although evidence is limited.

In summary, dermatitis artefacta is a rare condition that requires a multidisciplinary approach for management. Understanding the clinical features, risk factors, and differential diagnosis is crucial for accurate diagnosis and appropriate treatment.

According to the current British National Formulary, it is recommended to administer the vaccine at least 14 days prior to a planned splenectomy.

Splenectomy and its Management

Splenectomy is a surgical procedure that involves the removal of the spleen. After the operation, patients are at a higher risk of infections caused by pneumococcus, Haemophilus, meningococcus, and Capnocytophaga canimorsus. To prevent these infections, patients should receive vaccinations such as Hib, meningitis A & C, annual influenza, and pneumococcal vaccines. Antibiotic prophylaxis with penicillin V is also recommended for at least two years and until the patient is 16 years old, although some patients may require lifelong prophylaxis.

Splenectomy is indicated for various reasons such as trauma, spontaneous rupture, hypersplenism, malignancy, splenic cysts, hydatid cysts, and splenic abscesses. Elective splenectomy is different from emergency splenectomy, and it is usually performed laparoscopically. Complications of splenectomy include haemorrhage, pancreatic fistula, and thrombocytosis. Post-splenectomy changes include an increase in platelets, Howell-Jolly bodies, target cells, and Pappenheimer bodies. Patients are at an increased risk of post-splenectomy sepsis, which typically occurs with encapsulated organisms. Therefore, prophylactic antibiotics and pneumococcal vaccines are essential to prevent infections.

Importance of a Clear Publication Plan for Clinical Studies

A clear publication plan is essential for any clinical study. The study should be worthy of publication in some form, whether it is a local CCG journal or a peer-reviewed international publication. The research should provide learning outcomes that can improve clinical practice, and without publication, wider dissemination is impossible.

It is crucial to ensure that all staff involved in the study are aware of good medical practice, and patients should be provided with an information leaflet about the study. If the study is conducted in multiple areas, MREC approval means that the study can proceed without a separate full LREC application.

In summary, having a clear publication plan is crucial for any clinical study to ensure that the research findings are disseminated widely and can contribute to improving clinical practice.

Contra-indication of Amitriptyline in Recent Myocardial Infarction

Explanation: Patients who have recently experienced a myocardial infarction should avoid taking Amitriptyline as a treatment. This medication is not recommended for individuals who have suffered a heart attack in the past. Therefore, it is important to consult with a healthcare professional before taking any medication, especially if you have a history of heart disease. It is crucial to follow the doctor’s advice and avoid any medication that may cause harm to your health. Remember, prevention is always better than cure.

The Importance of Appraisal for GPs

Appraisal is a crucial process that has been mandatory for GPs since 2002. Its primary purpose is to identify areas for development rather than performance management. With the introduction of revalidation by the GMC, appraisals have become even more important as they provide a structured system for recording progress towards revalidation and identifying development needs.

After the Primary Care Trusts were disbanded, NHS England took on the responsibility for appraisals. The appraiser should be another GP who has been properly trained in appraisal. It is recommended that a doctor should have no more than three consecutive appraisals by the same appraiser in the same revalidation cycle. The average time commitment for appraisal is a minimum of 4.5 to 6.5 hours, including between 2 and 4 hours for preparation.

The content of appraisal is based on the 4 key domains set out in the GMC’s Good Medical Practice document. These domains include knowledge, skills, and performance, contributing and complying with systems to protect patients, communication, partnership, and teamwork, and maintaining trust. It is essential for GPs to participate in appraisal regularly to ensure they are providing the best possible care to their patients and maintaining their professional standards.

Assessment and Severity of Acute Asthma

Questions about the assessment and severity of acute asthma are common in exams. To address this, the British Thoracic Society (BTS) has provided clear guidance on the assessment and management of acute asthma. It is important to familiarize oneself with this document.

Indicators of acute severe asthma include a peak expiratory flow rate of 33-50% of the patient’s best or predicted rate, a respiratory rate of 25 or greater, a heart rate of 110/min or greater, or the inability to complete sentences in one breath. It is important to note that there is no fixed numerical peak flow rate for all patients, as it depends on their usual best reading or predicted peak flow reading. If their actual peak flow is 33-50% of this figure, then it is a marker of an acute severe attack.

According to BTS guidance, pulsus paradoxus is not an adequate indicator of the severity of an acute asthma attack and should not be used. A pulse of 101/min would not be considered a marker of acute severe asthma because the threshold is 110/min or greater. However, a respiratory rate of 26/min is clearly above the threshold advised by BTS and would be a marker of an acute severe attack. If any of these features of an acute severe asthma attack persist after initial treatment, then the patient should be admitted.

The most important blood test for diagnosing restless legs syndrome is measuring the ferritin level, as it is commonly associated with iron deficiency. While a full blood count may be performed to ensure the patient is not anemic, it is not the most likely test to be abnormal. Magnesium levels are not the most likely abnormality in this condition, although it may be appropriate to check along with other tests for a comprehensive assessment. Nerve conduction studies would not be warranted for a patient with restless leg syndrome unless there was diagnostic uncertainty and concern for possible nerve damage.

Restless Legs Syndrome: Symptoms, Causes, and Management

Restless legs syndrome (RLS) is a common condition that affects between 2-10% of the general population. It is characterized by spontaneous, continuous movements in the lower limbs, often accompanied by paraesthesia. Both males and females are equally affected, and a family history may be present. Symptoms typically occur at night but may progress to occur during the day, and are worse at rest. Movements during sleep may also be noted by a partner, known as periodic limb movements of sleep (PLMS).

There are several causes and associations with RLS, including a positive family history in 50% of patients with idiopathic RLS, iron deficiency anaemia, uraemia, diabetes mellitus, and pregnancy. Diagnosis is primarily clinical, although blood tests such as ferritin may be appropriate to exclude iron deficiency anaemia.

Management of RLS includes simple measures such as walking, stretching, and massaging affected limbs, as well as treating any underlying iron deficiency. Dopamine agonists such as Pramipexole and ropinirole are first-line treatments, while benzodiazepines and gabapentin may also be used. With proper management, individuals with RLS can experience relief from their symptoms and improve their quality of life.

Choosing the Right Pain Medication: A Guide to Opioids and Adjuvants

When it comes to managing pain, healthcare professionals often follow the World Health Organization’s analgesic ladder. This involves starting with non-opioid medications, such as paracetamol, and weak opioids, such as codeine, before moving on to stronger opioids like morphine if necessary.

In cases where bone pain or soft tissue infiltration is present, non-steroidal anti-inflammatory drugs like ibuprofen can be added as an adjuvant at any step in pain management. However, it is important to note that these adjuvants are unlikely to be a substitute for stronger opioids like morphine.

Dihydrocodeine and tramadol are both weak opioids and are therefore unlikely to provide significant pain relief in cases where stronger medication is needed. Amitriptyline, on the other hand, is an adjuvant typically used for neuropathic pain and is unlikely to be effective in this scenario.

For patients who require a strong opioid but are unable to take oral medication, fentanyl may be prescribed as a transdermal patch. Ultimately, the choice of pain medication and adjuvants will depend on the individual patient’s needs and the severity of their pain.